Skip to content

A comparative study of sympathoadrenal stress response modulation by intravenous versus nebulised dexmedetomidine during laryngoscopy and endotracheal intubation. A prospective randomised trial

A comparative study of sympathoadrenal stress response modulation by intravenous versus nebulised dexmedetomidine during laryngoscopy and endotracheal intubation. A prospective randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043841
Enrollment
120
Registered
2022-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous Dexmedetomidine: 1 mcg/kilogram body weight administered over 10 minutes prior to administration of anaesthesia. Control Intervention1: Nebulised Dexmedetomidine: 1 mcg/kilo

Sponsors

Shri Ram Murti Smarak Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18-60 years of either sex , ASA physical status I/II , Duration surgical procedures Undergoing short (parotidectomy, thyroidectomy, dental extractions, laparoscopic cholecystectomy) extending up to 2 hours will be enrolled in the study. (Duration of surgery was decided based upon the elimination half-life of the shorter acting of the two drugs involved in the study, in this case being dexmedetomidine (Elimination t1/2 -2 hrs))

Exclusion criteria

Exclusion criteria: Patient refusal, Hypersensitivity to the drugs being evaluated, History of pre-operative sore throat, Upper respiratory tract infection, Pregnancy, Chronic obstructive pulmonary disease/ Asthmatic patients, Cardiac patients, Hepatic/renal disease, Mallampatti grade >2, Body Mass Index (BMI) more than 40 kg/m2, Predicted difficult airway or unanticipated difficult intubation and those requiring laryngoscopy more than 15 secs or two attempts or more, Chronic use of opioids/opioid addiction, steroids, Inability to comprehend postoperatively neuropsychiatric disorders, Preoperative drugs that could be potential confounders (clonidine, gabapentin, pregabalin and steroids) The enlisted patients, who needed more than one intubation attempt or developed any intra-operative or post-operative complication included unanticipated change in surgical plan or increase in the duration of surgery were also excluded from further evaluation and analysis.

Design outcomes

Primary

MeasureTime frame
Change in heart rate, mean arterial pressures upon laryngoscopy and intubation as compared to pre laryngoscopy/ intubation and baseline levelsTimepoint: 0, 1min, 3 min, 5 min, 7 min, 10 min, 15 min, 30min, 45 min, 60 min, 75 min, 90 min, 105 min, 120 min

Secondary

MeasureTime frame
Compare effects of these routes on intraoperative analgesic consumption and incidence and sore throat post operativelyTimepoint: Post extubation, 1 hr, 2 hr, 4 hr, 6 hr, 8 hr, 12 hr, 24 hr

Countries

India

Contacts

Public ContactDr Vishwadeep Singh

SHRI RAM MURTI SMARAK INSTITUTE OF MEDICINE SCIENCES

vishwadeepvishen@gmail.com927770078

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026